Welcome to Kiran Infertility Center! The Surrogacy and Infertility Super-Specialty Clinic. The desire to have a baby is one of life's most important and exciting decisions. We at KIC, provide the latest updated technology and expertise, with the help of world class equipment and personalized care for for making your dream come true.
EMD Serono, Inc., an affiliate of Merck KGaA, Darmstadt, Germany, today announced the opening of a state-of-the-art research center in Billerica, MA, establishing it as a “hub” within the Merck KGaA research organization. Representing a $65 million investment, the Billerica research facility supports the company’s commitment to developing and discovering innovative treatments in oncology, neurodegenerative diseases and infertility. Nearly 100 new jobs will be added in Massachusetts as a result of the building expansion.
To view Multimedia News Release, go to
http://multivu.prnewswire.com/mnr/emdserono/48166/
The Kiran Infertility Centre- KIC is a Super Specialty Facility dealing in Infertility Treatments & Surrogacy. An ISO 9001- 2008 Company, KIC with its cutting-edge technology, world-renowned experts and a patient-centric approach, has been a dominant player in the area of Fertility Treatments and is one of the oldest facilities in India offering Infertility Treatment. Dr Samit Sekhar
The Kiran Infertility Centre- KIC is a Super Specialty Facility dealing in Infertility Treatments & Surrogacy. An ISO 9001- 2008 Company, KIC with its cutting-edge technology, world-renowned experts and a patient-centric approach, has been a dominant player in the area of Fertility Treatments and is one of the oldest facilities in India offering Infertility Treatment. Dr Sekhar Samit
The Kiran Infertility Centre- KIC is a Super Specialty Facility dealing in Infertility Treatments & Surrogacy. An ISO 9001- 2008 Company, KIC with its cutting-edge technology, world-renowned experts and a patient-centric approach, has been a dominant player in the area of Fertility Treatments and is one of the oldest facilities in India offering Infertility Treatment. Dr Pratima Grover
The Celiac Disease Center at Columbia University, the premier center for celiac disease research and treatment, unveiled the I Didn’t Know video campaign, offering an inside look at the serious impact of celiac disease on patients at the 13th Anniversary gala on November 13th in New York City. The series chronicles the lives of several patients experiencing a wide range of debilitating symptoms associated with undiagnosed celiac disease, including an inability to walk, developmental delays, multiple miscarriages and infertility.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7322351-celiac-disease-center-at-columbia-university-public-service-announcements-and-gala/
Following years of trying to expand their family, Lisa and James Park of Raleigh, NC were named the winning family in Ferring Pharmaceuticals’ 2014 Heart to Heart Video Contest. This marks the tenth year Ferring has provided educational grants through patient contests, giving parents who have struggled with infertility the chance to win thousands of dollars for their child’s education by sharing their story.
Lisa and James’ rollercoaster journey to parenthood included multiple rounds of in vitro fertilization (IVF), intrauterine insemination (IUI) and a frozen embryo transfer. They hope that by sharing their story and video, they can help raise awareness about infertility and provide hope for others facing similar struggles. You can view Park family’s full video at www.hearttoheartcontest.com.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7444651-ferring-pharmaceuticals-heart-to-heart/
https://www.FertilityFactor5.com/ct/8... Fertility Factor 5: Male Infertility? Here’s A New Male Fertility Supplement
Now, there is finally, an all-natural, way to improve male fertility. If you are trying to conceive but you have sperm with low count, poor shape or bad motility, here is a new product that can help you with these issues.
